Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05276557 · ClinicalTrials.gov registry record · Phase 3
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
A Phase 3 study of Safety and Efficacy, sponsored by ARJ Medical.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT05276557 is a Phase 3 study of Safety and Efficacy that is actively recruiting participants, run by ARJ Medical. The registered enrollment target is 40 participants, below the 125-participant average among 10 other Safety trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05276557, a Phase 3 study of Safety and Efficacy, is actively recruiting participants, sponsored by ARJ Medical.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a multi-center, non-randomized, open label study. Subjects will be enrolled on a walk-in basis. Screening data will be reviewed to determine subject eligibility. Subjects who meet all inclusion criteria and none of the exclusion criteria will be entered into the study. All children will be exposed to non-radioactive 13C-Urea with citric acid, and shall submit a stool sample. Centers will house a PyloPlus UBT Analyzer to document results. PyloPlus Analyzer results shall remain blinded to the investigator and treating physician. No patient management decisions should be made based on the investigational PyloPlus® UBT System. Treating physician will prescribe a H. Pylori Stool Antigen Test to Stool test at either LabCorp or Quest Diagnostic, for the patient, which will be used for diagnostic purposes by the ordering physician. Total duration of study is anticipated to be approximately 6 months.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Stool Antigen Test
- COMBINATION_PRODUCT PyloPlus Urea Breath Test System
Study Locations (3)
Florida
- Dolphin Medical Research - Doral
- Orlando Health, Inc. - Orlando
Texas
- Harmony United Research - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-11-17 |
| Est. Completion | 2023-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05276557
The ClinicalTrials.gov registry entry for NCT05276557 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 125-participant average among 10 other Safety trials with a reported enrollment target (68% lower). The listed sponsor is ARJ Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Safety appearing as the primary indexed condition, and to 2 interventions - of which Stool Antigen Test is the first listed.
NCT05276557 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT05276557 about?
NCT05276557 is a clinical study titled "PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study". This is a multi-center, non-randomized, open label study. Subjects will be enrolled on a walk-in basis. Screening data will be reviewed to determine subject eligibility. Subjects who meet all inclusion criteria and none of the exclusion criteria will be entered into the study. All children will be e...
What is the current status of trial NCT05276557?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2022-11-17. Estimated completion is 2023-06.
What conditions does trial NCT05276557 study?
This clinical trial studies the following conditions: Safety, Efficacy, Helicobacter Pylori.
What interventions are being tested in trial NCT05276557?
The interventions under investigation include: Stool Antigen Test (DIAGNOSTIC_TEST), PyloPlus Urea Breath Test System (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05276557?
This trial is sponsored by ARJ Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05276557 being conducted?
This trial has 3 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Curcumin and Retinal Study
RECRUITING · Phase 1
-
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
RECRUITING · Phase 1
-
Prospective G7 Dual Mobility Total Hip PMCF
ACTIVE NOT RECRUITING
-
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
COMPLETED · Phase 4
-
Developing a Dyadic Shared Decision Making Tool About Firearm Storage
COMPLETED · NA
-
Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.